e-Therapeutics raises £21 million, Invesco to hold 48% stake
This article was originally published in Scrip
Executive Summary
e-Therapeutics, which finds new uses for old drugs, has secured around £21 million of financing through new and existing investors to enable it to advance its lead programmes to stage where they will be ready for out-licensing, the UK company said.